The cervical cancer related distribution, coinfection and risk of 15 HPV types in Baoan, Shenzhen, in 2017-2023.

Rukai Li, Weiwei Meng, Yunhai Zuo, Yanli Xu, Shaonan Wu
Author Information
  1. Rukai Li: Shenzhen Baoan Shiyan People's Hospital, No. 11 Jixiang Road, Shiyan, Baoan District, Shenzhen, 518108, China. rkli2024@163.com.
  2. Weiwei Meng: Shenzhen Baoan Shiyan People's Hospital, No. 11 Jixiang Road, Shiyan, Baoan District, Shenzhen, 518108, China.
  3. Yunhai Zuo: Shenzhen Baoan Shiyan People's Hospital, No. 11 Jixiang Road, Shiyan, Baoan District, Shenzhen, 518108, China.
  4. Yanli Xu: Shenzhen Baoan Shiyan People's Hospital, No. 11 Jixiang Road, Shiyan, Baoan District, Shenzhen, 518108, China.
  5. Shaonan Wu: Shenzhen Baoan Shiyan People's Hospital, No. 11 Jixiang Road, Shiyan, Baoan District, Shenzhen, 518108, China.

Abstract

Cervical cancer is one of the most common malignant tumours. Human papillomavirus (HPV) infection is the main cause of this cancer so that it could be prevented by screening and early treatment. Developing reginal screen protocols of maximum public health efficacy requires in-depth understandings of local HPV distribution and consequential cancer risks. Therefore, test results of HPV genotyping, cytology testing (TCT) and colposcopy inspection with biopsy were collected in this retrospective research. Data included by this research involved 63,906 women received screen related tests from Shenzhen Baoan Shiyan People's Hospital and the subsidiary institutes between 2017.01 and 2023.05. 10,238 colposcopies were performed in this period collecting 8,716 samples and 814 high-grade CIN were discovered. Within the 763 high-grade CIN cases with both TCT and HPV testing results, 232 were tested cytologically normal but only 30 were negative in HPV test. Besides, the rates of high-grade CIN observed in coinfection were all lower than the estimated rates generated from related single infection. HPV 52, 58 and 16 were found to be the most common types in Baoan, Shenzhen. The result also suggested that HPV coinfections should not increase risk for cervical cancers.

Keywords

References

  1. Hum Vaccin Immunother. 2023 Aug 1;19(2):2241309 [PMID: 37519009]
  2. PLoS One. 2017 Nov 21;12(11):e0187844 [PMID: 29161285]
  3. Nat Commun. 2020 Jun 5;11(1):2841 [PMID: 32503989]
  4. Cancer Prev Res (Phila). 2017 Dec;10(12):745-751 [PMID: 28916509]
  5. Indian J Gynecol Oncol. 2021;19(3):51 [PMID: 34222614]
  6. J Infect Dis. 2011 Apr 1;203(7):910-20 [PMID: 21402543]
  7. N Engl J Med. 2015 Feb 19;372(8):711-23 [PMID: 25693011]
  8. Papillomavirus Res. 2016 Dec;2:112-115 [PMID: 29074170]
  9. CA Cancer J Clin. 2021 May;71(3):209-249 [PMID: 33538338]
  10. Gynecol Oncol. 2015 Apr;137(1):47-54 [PMID: 25667973]
  11. Cancer. 2019 Apr 1;125(7):1030-1037 [PMID: 30748006]
  12. BMC Cancer. 2017 Aug 8;17(1):531 [PMID: 28789619]
  13. Viruses. 2021 Jul 12;13(7): [PMID: 34372548]
  14. Front Oncol. 2020 Apr 07;10:449 [PMID: 32318343]
  15. Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:22-36 [PMID: 30306584]
  16. J Pathol Transl Med. 2022 Sep;56(5):289-293 [PMID: 36128865]
  17. Lancet Oncol. 2010 Nov;11(11):1048-56 [PMID: 20952254]
  18. BMC Cancer. 2022 Jan 6;22(1):42 [PMID: 34991494]
  19. Gynecol Oncol. 2014 Sep;134(3):534-9 [PMID: 24979052]
  20. Semin Oncol Nurs. 2017 May;33(2):172-183 [PMID: 28343836]
  21. Gynecol Oncol. 2015 Feb;136(2):189-97 [PMID: 25579108]
  22. Vaccines (Basel). 2024 Jan 12;12(1): [PMID: 38250888]
  23. Medicine (Baltimore). 2020 Sep 18;99(38):e22320 [PMID: 32957398]
  24. J Med Virol. 2021 Aug;93(8):5103-5109 [PMID: 33847386]
  25. J Low Genit Tract Dis. 2017 Oct;21(4):216-222 [PMID: 28953109]
  26. Acta Cytol. 2015;59(5):391-8 [PMID: 26674365]
  27. Zhonghua Yi Xue Za Zhi. 2023 Apr 10;103:1184-1195 [PMID: 37062594]
  28. Chin Med J (Engl). 2021 Mar 17;134(7):783-791 [PMID: 33734139]
  29. Lancet Glob Health. 2022 Aug;10(8):e1115-e1127 [PMID: 35839811]
  30. Microbiol Immunol. 2021 Jul;65(7):273-278 [PMID: 34133044]
  31. Cancer Cytopathol. 2022 Apr;130(4):248-258 [PMID: 34874615]
  32. Best Pract Res Clin Obstet Gynaecol. 2020 May;65:109-124 [PMID: 32284298]
  33. Virol J. 2021 Oct 20;18(1):208 [PMID: 34670576]
  34. Virol J. 2022 Oct 7;19(1):157 [PMID: 36207729]
  35. PLoS One. 2021 Dec 2;16(12):e0260915 [PMID: 34855928]
  36. J Cancer. 2020 Aug 25;11(20):6157-6167 [PMID: 32922555]
  37. Transl Cancer Res. 2022 Sep;11(9):3277-3286 [PMID: 36237241]

MeSH Term

Humans
Female
Papillomavirus Infections
Uterine Cervical Neoplasms
China
Coinfection
Adult
Retrospective Studies
Papillomaviridae
Middle Aged
Genotype
Young Adult
Uterine Cervical Dysplasia
Colposcopy
Early Detection of Cancer
Aged

Word Cloud

Created with Highcharts 10.0.0HPVcancerTCTrelatedShenzhenBaoanhigh-gradeCINCervicalcommoninfectionscreendistributiontestresultstestingresearchratescoinfectiontypesriskcervicalonemalignanttumoursHumanpapillomavirusmaincausepreventedscreeningearlytreatmentDevelopingreginalprotocolsmaximumpublichealthefficacyrequiresin-depthunderstandingslocalconsequentialrisksThereforegenotypingcytologycolposcopyinspectionbiopsycollectedretrospectiveDataincludedinvolved63906womenreceivedtestsShiyanPeople'sHospitalsubsidiaryinstitutes20170120230510238colposcopiesperformedperiodcollecting8716samples814discoveredWithin763cases232testedcytologicallynormal30negativeBesidesobservedlowerestimatedgeneratedsingle525816foundresultalsosuggestedcoinfectionsincreasecancers152017-2023CoinfectionColposcopy

Similar Articles

Cited By